المؤلفون: Clément Bodineau, Benjamin Uzan, Sebastian van Liempd, Jean-Max Pasquet, Juan M. Falcón-Pérez, Elodie Muzotte, H. Rezvani, Julien Calvo, Elodie Richard, María L. Toribio, Patricia Fuentes, Isabelle Redonnet-Vernhet, Silvia Terés, Marion Bouchecareilh, Mercedes Tomé, Pierre Soubeyran, Piedad del Socorro Murdoch, Benoit Rousseau, Tra Ly Nguyen, Françoise Pflumio, Marie-Julie Nokin, Oriane Galmar, Raúl V. Durán, Abdel-Majid Khatib, Muriel Priault

المساهمون: Centre National de la Recherche Scientifique (CNRS), Universidad de Sevilla. Departamento de Bioquímica Vegetal y Biología Molecular, Ministerio de Ciencia, Innovación y Universidades (MICINN). España, European Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER), Agencia Estatal de Investigación (España), European Commission, Ministerio de Ciencia, Innovación y Universidades (España), Ministerio de Economía y Competitividad (España), Consejo Superior de Investigaciones Científicas (España), Institut National de la Santé et de la Recherche Médicale (France), Ligue Nationale contre le Cancer (France), Université de Bordeaux, Fondation pour la Recherche Médicale, Conseil régional d'Aquitaine, Fondation ARC pour la Recherche sur le Cancer, Fonds de la Recherche Scientifique (Fédération Wallonie-Bruxelles), Actions for OnCogenesis understanding and Target Identification in ONcology (ACTION), Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire Angiogenèse et Micro-environnement des Cancers (LAMC), Université Sciences et Technologies - Bordeaux 1-Institut National de la Santé et de la Recherche Médicale (INSERM), Biothérapies des maladies génétiques et cancers, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de biochimie et génétique cellulaires (IBGC), Université Bordeaux Segalen - Bordeaux 2-Centre National de la Recherche Scientifique (CNRS), Bordeaux Research In Translational Oncology [Bordeaux] (BaRITOn), Université de Bordeaux (UB)-CHU Bordeaux [Bordeaux]-Institut National de la Santé et de la Recherche Médicale (INSERM), [Nguyen,TL, Nokin,MJ, Terés,S, Bodineau,C, Galmnar,O, Durán,RV] Institut Europeen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France. [Tomé,M, Murdoch,PDS, Durán,RV] Centro Andaluz de Biología Molecular y Medicina Regenerativa - CABIMER, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Universidad Pablo de Olavide, Seville, Spain. [Tomé,M, Khatib,AM] Angiogenesis and Cancer Microenvironment Laboratory INSERM U1029, Universite de Bordeaux, Pessac, France. [Pasquet,JM, Muzotte,E, Rezvani,HR] INSERM, BMGIC, U1035, University of Bordeaux, France. [Rousseau,B] Service Commun des Animaleries, University of Bordeaux, France. [van Liempd,S, Falcon-Perez,JM] Exosomes Laboratory and Platform of Metabolomics, CIC bioGUNE, CIBERehd, Derio, Spain. [Falcon-Perez,JM] IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. [Richard,E] Institut Bergonie, INSERM U1218, University of Bordeaux, France. [Priault,M] Institut de Biochimie et Gen etique Cellulaires, CNRS UMR 5095, Université de Bordeaux, France. [Bouchecareilh,M] Bordeaux Research in Translational Oncology, INSERM U1053, Universite de Bordeaux, France. [Redonnet-Vernhet,I] Maladies Heréditaires du Métabolisme, Laboratoire de Biochimie, Hôpital Pellegrin, CHU Bordeaux, France. [Calvo,J, Uzan,B, Pflumio, F] UMR967, Inserm, CEA, Universite Paris 7, UniversitéParis 11, Fontenay-aux-Roses, France. [Fuentes,P, Toribio,ML] Centro de Biología Molecular 'Severo Ochoa', Consejo Superior de Investigaciones Científicas, Universidad Autonoma de Madrid, Spain. [Murdoch,PDS] Departamento de Bioquímica Vegetal y Biología Molecular, Universidad de Sevilla, Spain, This work was supported by funds from the following institutions: Agencia Estatal de Investigación/European Regional Development Fund, European Union (PGC2018-096244-B-I00, SAF2016-75442-R), Ministry of Science, Innovation and Universities of Spain, Spanish National Research Council—CSIC, Institut National de la Santé et de la Recherche Médicale—INSERM, Ligue Contre le Cancer—Gironde, Université de Bordeaux, Fondation pour la Recherche Médicale, the Conseil Régional d'Aquitaine, SIRIC-BRIO, Fondation ARC and Institut Européen de Chimie et Biologie. MJN was supported by a bourse d’excellence de la Fédération Wallonie-Bruxelles (WBI) and a postdoctoral fellowship from Fondation ARC. We thank Vincent Pitard (Flow Cytometry Platform, Université de Bordeaux, France) for technical assistance in flow cytometry experiments. We thank Diana Cabrera (Metabolomics Platform, CIC bioGUNE, Spain) for technical assistance in metabolomics analysis.

المصدر: Molecular Oncology
Molecular Oncology, Elsevier, 2021, 15 (5), pp.1412-1431. ⟨10.1002/1878-0261.12877⟩
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Molecular Oncology, Elsevier, 2021, 15, pp.1412-1431. ⟨10.1002/1878-0261.12877⟩
Digital.CSIC. Repositorio Institucional del CSIC
Molecular Oncology, Vol 15, Iss 5, Pp 1412-1431 (2021)

مصطلحات موضوعية: 0301 basic medicine, Male, Anatomy::Cells::Cells, Cultured::Cell Line::Cell Line, Tumor [Medical Subject Headings], Cancer Research, Glutamina, Regulación hacia abajo, [SDV]Life Sciences [q-bio], Glutamine, mTORC1, [SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC], Diana mecanicista del complejo 1 de la rapamicina, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Mice, 0302 clinical medicine, Mice, Inbred NOD, hemic and lymphatic diseases, Organisms::Eukaryota::Animals [Medical Subject Headings], Receptor, Notch1, Research Articles, RC254-282, ComputingMilieux_MISCELLANEOUS, Metabolismo, Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes [Medical Subject Headings], Organisms::Eukaryota::Animals::Animal Population Groups::Animals, Laboratory::Animals, Inbred Strains::Mice, Inbred Strains::Mice, Inbred NOD [Medical Subject Headings], Chemistry, Gene Expression Regulation, Leukemic, Línea celular, Metabolicaddiction, Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Signal Transduction [Medical Subject Headings], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, 3. Good health, Leukemia, Oncology, 030220 oncology & carcinogenesis, embryonic structures, cardiovascular system, Molecular Medicine, biological phenomena, cell phenomena, and immunity, Glutamato-amoníaco ligasa, T-cell acute lymphoblastic leukemia, Research Article, Signal Transduction, Receptor Notch1, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Notch::Receptor, Notch1 [Medical Subject Headings], Down-Regulation, Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Gene Expression Regulation, Neoplastic::Gene Expression Regulation, Leukemic [Medical Subject Headings], Check Tags::Male [Medical Subject Headings], Mice, Transgenic, [SDV.CAN]Life Sciences [q-bio]/Cancer, Mechanistic Target of Rapamycin Complex 1, Gene Expression Regulation, Enzymologic, Glutamine synthetase, 03 medical and health sciences, Downregulation and upregulation, Glutamate-Ammonia Ligase, Cell Line, Tumor, T‐cell acute lymphoblastic leukemia, Diseases::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid::Precursor Cell Lymphoblastic Leukemia-Lymphoma [Medical Subject Headings], Genetics, medicine, Animals, Humans, Metabolic addiction, T-cell acutelymphoblastic leukemia, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Mice [Medical Subject Headings], Notch1, Glutaminolysis, Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Down-Regulation [Medical Subject Headings], Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Up-Regulation [Medical Subject Headings], Cell growth, Leucemia-linfoma linfoblástico de células T precursoras, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Amino Acids::Amino Acids, Basic::Glutamine [Medical Subject Headings], medicine.disease, Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Ligases::Carbon-Nitrogen Ligases::Amide Synthases::Glutamate-Ammonia Ligase [Medical Subject Headings], Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Gene Expression Regulation, Enzymologic [Medical Subject Headings], 030104 developmental biology, Apoptosis, Downregulation, metabolic addiction, Cancer research, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Mice::Mice, Transgenic [Medical Subject Headings], sense organs, Cell line

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274dd93100a7d24ada66a7c0aca2aad0
https://hal-cnrs.archives-ouvertes.fr/hal-03401225

المؤلفون: Nokin MJ; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium. Electronic address: mjnokin@uliege.be., Darbo E; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France., Richard E; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France., San José S; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain., de Hita S; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain., Prouzet-Mauleon V; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; CRISP'edit, TBMCore, University of Bordeaux, CNRS UAR 3427, INSERM US05, 33000 Bordeaux, France., Turcq B; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; CRISP'edit, TBMCore, University of Bordeaux, CNRS UAR 3427, INSERM US05, 33000 Bordeaux, France., Gerardelli L; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Crake R; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Velasco V; Department of Biopathology, Institut Bergonié, 33076 Bordeaux, France., Koopmansch B; Department of Human Genetics, University Hospital Center of Liege, 4000 Liege, Belgium., Lambert F; Department of Human Genetics, University Hospital Center of Liege, 4000 Liege, Belgium., Xue JY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sang B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Horne J; Laboratory of Pharmaceutical Analytical Chemistry, CIRM, University of Liege, 4000 Liege, Belgium., Ziemons E; Laboratory of Pharmaceutical Analytical Chemistry, CIRM, University of Liege, 4000 Liege, Belgium., Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO); Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Blomme A; Laboratory of Cancer Signaling, GIGA-Stem Cells, University of Liege, 4000 Liege, Belgium., Herfs M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Cataldo D; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Calvayrac O; Cancer Research Centre of Toulouse, INSERM UMR1037, CNRS UMR5071, 31100 Toulouse, France., Porporato P; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy., Nadal E; Molecular Mechanisms of Cancer Program, Department of Medical Oncology, Catalan Institute of Oncology (ICO), Preclinical and Experimental Research in Thoracic Tumors (PReTT) Group, Oncobell Program, IDIBELL, L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Lito P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ricciuti B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy. Electronic address: chiara.ambrogio@unito.it., Santamaría D; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain. Electronic address: d.santamaria@usal.es.

مؤلفون مشاركون: Bolero Consortium

المصدر: Cell reports. Medicine [Cell Rep Med] 2024 Jul 23, pp. 101663. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

المؤلفون: Nokin MJ, Durieux F, Peixoto P, Chiavarina B, Peulen O, Blomme A, Turtoi A, Costanza B, Smargiasso N, Baiwir D, Scheijen JL, Schalkwijk CG, Leenders J, De Tullio P, Bianchi E, Thiry M, Uchida K, Spiegel DA, Cochrane JR, Hutton CA, De Pauw E, Delvenne P, Belpomme D, Castronovo V, Bellahcène A

المصدر: ELife [Elife] 2024 Feb 06; Vol. 13. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Dube G; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Tiamiou A; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Boumahd Y; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Gasmi I; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Crake R; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Bellier J; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Nokin MJ; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Calonne E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Deplus R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Wissocq T; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Peulen O; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Castronovo V; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.; WELBIO (Walloon Excellence in Lifesciences & Biotechnology), Brussels, Belgium., Bellahcène A; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium. a.bellahcene@uliege.be.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Mar 31; Vol. 42 (1), pp. 78. Date of Electronic Publication: 2023 Mar 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: DNA Methylation* , Triple Negative Breast Neoplasms*/metabolism, Humans ; Pyruvaldehyde/metabolism ; Cell Line, Tumor ; Transcriptome ; Gene Expression Regulation, Neoplastic

المؤلفون: Bendavid G; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium.; Department of Otorhinolaryngology Head and Neck Surgery, University of Liege (ULiege) and Centre Hospitalier Universitaire (CHU) Liege, Liege, Belgium., Hubeau C; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Perin F; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Gillard A; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Nokin MJ; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Carnet O; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Gerard C; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Noel A; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Lefebvre P; Department of Otorhinolaryngology Head and Neck Surgery, University of Liege (ULiege) and Centre Hospitalier Universitaire (CHU) Liege, Liege, Belgium., Rocks N; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium., Cataldo D; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege (ULiege), Liege, Belgium.; Department of respiratory diseases, University of Liege (ULiege) and Centre Hospitalier Universitaire (CHU) Liege, Liege, Belgium.

المصدر: Frontiers in immunology [Front Immunol] 2023 Jan 05; Vol. 13, pp. 1067779. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Airway Remodeling* , Asthma*/metabolism, Mice ; Animals ; Hyperplasia/pathology ; Bronchoalveolar Lavage Fluid ; Disease Models, Animal ; Lung ; Inflammation/metabolism ; Allergens/metabolism ; Metalloproteases/metabolism

المؤلفون: Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Son J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Okoro JJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Mira A; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy., Patrucco E; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy., Eum Y; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Wang X; Harvard Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts., Paranal R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Wang H; School of Life Sciences and Technology, Tongji University, Shanghai, China., Lin M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Haikala HM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Li J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Xu Y; School of Life Sciences and Technology, Tongji University, Shanghai, China., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Chhoeu C; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Redig AJ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Köhler J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Dholakia KH; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Chen Y; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Richard E; Institut Bergonié, INSERM U1218, ACTION Laboratory, Bordeaux, France., Nokin MJ; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, Pessac, France., Santamaria D; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, Pessac, France., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Ambrogio C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 14; Vol. 28 (8), pp. 1640-1650.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Humans ; Kelch-Like ECH-Associated Protein 1/genetics ; Mitogen-Activated Protein Kinase Kinases/genetics ; Mutation ; NF-E2-Related Factor 2/genetics ; Protein Isoforms/genetics ; Proto-Oncogene Proteins p21(ras)/genetics

المؤلفون: Kaminski H; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Marseres G; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Yared N; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Nokin MJ; Actions for onCogenesis understanding and Target Identification in ONcology, Institut Europeen de chimie et de biologie, Institut National de la Santé et de la Recherche Médicale, U1218, University of Bordeaux, Pessac, France., Pitard V; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.; Centre National de la Recherche Scientifique Unité Mixte de Service 3427, Institut National de la Santé et de la Recherche Médicale US 005, TransBioMed Core, Flow Cytometry Facility, University of Bordeaux, Bordeaux, France., Zouine A; Centre National de la Recherche Scientifique Unité Mixte de Service 3427, Institut National de la Santé et de la Recherche Médicale US 005, TransBioMed Core, Flow Cytometry Facility, University of Bordeaux, Bordeaux, France., Garrigue I; Virology Department, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5234 and CHU Bordeaux, University of Bordeaux, Bordeaux, France., Loizon S; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Capone M; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Gauthereau X; Centre National de la Recherche Scientifique Unité Mixte de Service 3427, Institut National de la Santé et de la Recherche Médicale US 005, TransBioMed Core, PCRq'UB, University of Bordeaux, Bordeaux, France., Mamani-Matsuda M; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Coueron R; Institut National de la Santé et de la Recherche Médicale U1219 Bordeaux Population Health Research Center, Inria SISTM, University of Bordeaux, Bordeaux, France., Durán RV; Actions for onCogenesis understanding and Target Identification in ONcology, Institut Europeen de chimie et de biologie, Institut National de la Santé et de la Recherche Médicale, U1218, University of Bordeaux, Pessac, France., Pinson B; Centre National de la Recherche Scientifique Unité Mixte de Service 3427, Institut National de la Santé et de la Recherche Médicale US 005, TransBioMed Core, Service Analyses Métaboliques, University of Bordeaux, Bordeaux, France.; Centre National de la Recherche Scientifique, Institut de Biochimie et Genetique Cellulaire Unité Mixte de Recherche 5095, University of Bordeaux, Bordeaux, France., Pellegrin I; Laboratory of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France., Thiébaut R; Institut National de la Santé et de la Recherche Médicale U1219 Bordeaux Population Health Research Center, Inria SISTM, University of Bordeaux, Bordeaux, France., Couzi L; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Merville P; Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France.; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France., Déchanet-Merville J; ImmunoConcEpT, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5164, University of Bordeaux, Bordeaux, France.

المصدر: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2022 Jan; Vol. 33 (1), pp. 121-137. Date of Electronic Publication: 2021 Nov 01.

نوع المنشور: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Cytomegalovirus Infections/*prevention & control , Kidney Transplantation/*adverse effects , MTOR Inhibitors/*therapeutic use , T-Lymphocyte Subsets/*drug effects, Aged ; Anti-Bacterial Agents/therapeutic use ; Antigens, CD/metabolism ; Cell Culture Techniques ; Cytomegalovirus Infections/epidemiology ; Cytomegalovirus Infections/pathology ; Female ; Humans ; Leukocyte Immunoglobulin-like Receptor B1/metabolism ; Male ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Programmed Cell Death 1 Receptor/metabolism ; T-Lymphocyte Subsets/metabolism

المؤلفون: Nokin MJ; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nadal E; Department of Medical Oncology, Catalan Institute of Oncology, Clinical Research in Solid Tumors (CReST) Group, Oncobell Program, IDIBELL, L'Hospitalet, Barcelona, Spain. Electronic address: esnadal@iconcologia.net., Santamaria D; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France. Electronic address: d.santamaria@iecb.u-bordeaux.fr.

المصدر: Trends in cancer [Trends Cancer] 2021 May; Vol. 7 (5), pp. 410-429. Date of Electronic Publication: 2020 Dec 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Precision Medicine/*methods , Proto-Oncogene Proteins/*antagonists & inhibitors, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinogenesis/drug effects ; Carcinogenesis/genetics ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/mortality ; Clinical Trials as Topic ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Drug Synergism ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Lung Neoplasms/genetics ; Lung Neoplasms/immunology ; Lung Neoplasms/mortality ; Molecular Targeted Therapy/methods ; Mutation ; Progression-Free Survival ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins/genetics

المؤلفون: Nguyen TL; Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France., Nokin MJ; Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France., Terés S; Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France., Tomé M; Centro Andaluz de Biología Molecular y Medicina Regenerativa - CABIMER, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Universidad Pablo de Olavide, Seville, Spain.; Angiogenesis and Cancer Microenvironment Laboratory INSERM U1029, Université de Bordeaux, Pessac, France., Bodineau C; Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France.; Centro Andaluz de Biología Molecular y Medicina Regenerativa - CABIMER, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Universidad Pablo de Olavide, Seville, Spain., Galmar O; Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France., Pasquet JM; INSERM, BMGIC, U1035, University of Bordeaux, France., Rousseau B; Service Commun des Animaleries, University of Bordeaux, France., van Liempd S; Exosomes Laboratory and Platform of Metabolomics, CIC bioGUNE, CIBERehd, Derio, Spain., Falcon-Perez JM; Exosomes Laboratory and Platform of Metabolomics, CIC bioGUNE, CIBERehd, Derio, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain., Richard E; Institut Bergonié, INSERM U1218, University of Bordeaux, France., Muzotte E; INSERM, BMGIC, U1035, University of Bordeaux, France., Rezvani HR; INSERM, BMGIC, U1035, University of Bordeaux, France., Priault M; Institut de Biochimie et Génétique Cellulaires, CNRS UMR 5095, Université de Bordeaux, France., Bouchecareilh M; Bordeaux Research in Translational Oncology, INSERM U1053, Université de Bordeaux, France., Redonnet-Vernhet I; Maladies Héréditaires du Métabolisme, Laboratoire de Biochimie, Hôpital Pellegrin, CHU Bordeaux, France., Calvo J; UMR967, Inserm, CEA, Université Paris 7, Université Paris 11, Fontenay-aux-Roses, France., Uzan B; UMR967, Inserm, CEA, Université Paris 7, Université Paris 11, Fontenay-aux-Roses, France., Pflumio F; UMR967, Inserm, CEA, Université Paris 7, Université Paris 11, Fontenay-aux-Roses, France., Fuentes P; Centro de Biología Molecular 'Severo Ochoa', Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Spain., Toribio ML; Centro de Biología Molecular 'Severo Ochoa', Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Spain., Khatib AM; Angiogenesis and Cancer Microenvironment Laboratory INSERM U1029, Université de Bordeaux, Pessac, France., Soubeyran P; Institut Bergonié, INSERM U1218, University of Bordeaux, France., Murdoch PDS; Centro Andaluz de Biología Molecular y Medicina Regenerativa - CABIMER, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Universidad Pablo de Olavide, Seville, Spain.; Departamento de Bioquímica Vegetal y Biología Molecular, Universidad de Sevilla, Spain., Durán RV; Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, Pessac, France.; Centro Andaluz de Biología Molecular y Medicina Regenerativa - CABIMER, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Universidad Pablo de Olavide, Seville, Spain.

المصدر: Molecular oncology [Mol Oncol] 2021 May; Vol. 15 (5), pp. 1412-1431. Date of Electronic Publication: 2021 Feb 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glutamate-Ammonia Ligase/*genetics , Glutamine/*metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*metabolism, Animals ; Cell Line, Tumor ; Down-Regulation/genetics ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Leukemic ; Glutamate-Ammonia Ligase/metabolism ; Humans ; Male ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Mice ; Mice, Inbred NOD ; Mice, Transgenic ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Receptor, Notch1/genetics ; Receptor, Notch1/metabolism ; Signal Transduction/genetics

المؤلفون: Hubert P; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Roncarati P; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Demoulin S; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Pilard C; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Ancion M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Reynders C; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Lerho T; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Bruyere D; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Lebeau A; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Radermecker C; Laboratory of Immunophysiology, GIGA-I3, University of Liege, Liege, Belgium.; Faculty of Veterinary Medicine, University of Liege, Liege, Belgium., Meunier M; Laboratory of Immunophysiology, GIGA-I3, University of Liege, Liege, Belgium.; Faculty of Veterinary Medicine, University of Liege, Liege, Belgium., Nokin MJ; Metastasis Research Laboratory, GIGA-Cancer, University of Liege, Liege, Belgium., Hendrick E; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium., Peulen O; Metastasis Research Laboratory, GIGA-Cancer, University of Liege, Liege, Belgium., Delvenne P; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium.; Department of Pathology, University Hospital Center of Liege, Liege, Belgium., Herfs M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium M.Herfs@uliege.be.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*pharmacology , Breast Neoplasms/*drug therapy , Carcinoma, Non-Small-Cell Lung/*drug therapy , Glycyrrhizic Acid/*pharmacology , HMGB1 Protein/*antagonists & inhibitors , Immune Checkpoint Inhibitors/*pharmacology , Lung Neoplasms/*drug therapy , Peptide Fragments/*pharmacology , S100 Proteins/*pharmacology , Tumor Microenvironment/*immunology , Uterine Cervical Neoplasms/*drug therapy, Adaptive Immunity/drug effects ; Animals ; Breast Neoplasms/immunology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Female ; HMGB1 Protein/metabolism ; Humans ; Lung Neoplasms/immunology ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Macrophages/drug effects ; Macrophages/immunology ; Macrophages/metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Nude ; RAW 264.7 Cells ; Signal Transduction ; Tumor Burden/drug effects ; Uterine Cervical Neoplasms/immunology ; Uterine Cervical Neoplasms/metabolism ; Uterine Cervical Neoplasms/pathology